India · Delayed Price · Currency is INR Strides Pharma Science Statistics
Total Valuation
BOM:532531 has a market cap or net worth of INR 88.26 billion. The enterprise value is 104.21 billion.
| Market Cap | 88.26B |
| Enterprise Value | 104.21B |
Important Dates
The last earnings date was Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Jul 31, 2026 |
Share Statistics
| Current Share Class | 92.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 7.28% |
| Owned by Institutions (%) | 28.85% |
| Float | 56.70M |
Valuation Ratios
The trailing PE ratio is 14.39 and the forward PE ratio is 12.79.
| PE Ratio | 14.39 |
| Forward PE | 12.79 |
| PS Ratio | 1.76 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 5.15 |
| P/FCF Ratio | 31.01 |
| P/OCF Ratio | 12.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.28, with an EV/FCF ratio of 36.62.
| EV / Earnings | 16.99 |
| EV / Sales | 2.08 |
| EV / EBITDA | 12.28 |
| EV / EBIT | 15.96 |
| EV / FCF | 36.62 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.56 |
| Debt / EBITDA | 2.07 |
| Debt / FCF | 6.18 |
| Interest Coverage | 4.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.82% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 14.16M |
| Profits Per Employee | 1.74M |
| Employee Count | 3,535 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532531 has paid 1.12 billion in taxes.
| Income Tax | 1.12B |
| Effective Tax Rate | 14.99% |
Stock Price Statistics
The stock price has increased by +14.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +14.42% |
| 50-Day Moving Average | 1,052.24 |
| 200-Day Moving Average | 975.25 |
| Relative Strength Index (RSI) | 45.68 |
| Average Volume (20 Days) | 34,086 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532531 had revenue of INR 50.04 billion and earned 6.13 billion in profits. Earnings per share was 66.55.
| Revenue | 50.04B |
| Gross Profit | 28.12B |
| Operating Income | 6.54B |
| Pretax Income | 7.46B |
| Net Income | 6.13B |
| EBITDA | 8.20B |
| EBIT | 6.54B |
| Earnings Per Share (EPS) | 66.55 |
Balance Sheet
The company has 2.04 billion in cash and 17.58 billion in debt, with a net cash position of -15.54 billion.
| Cash & Cash Equivalents | 2.04B |
| Total Debt | 17.58B |
| Net Cash | -15.54B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.49B |
| Book Value Per Share | 337.15 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 7.03 billion and capital expenditures -4.18 billion, giving a free cash flow of 2.85 billion.
| Operating Cash Flow | 7.03B |
| Capital Expenditures | -4.18B |
| Depreciation & Amortization | 1.66B |
| Net Borrowing | -2.40B |
| Free Cash Flow | 2.85B |
| FCF Per Share | n/a |
Margins
Gross margin is 56.19%, with operating and profit margins of 13.07% and 12.26%.
| Gross Margin | 56.19% |
| Operating Margin | 13.07% |
| Pretax Margin | 14.91% |
| Profit Margin | 12.26% |
| EBITDA Margin | 16.39% |
| EBIT Margin | 13.07% |
| FCF Margin | 5.86% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | 0.40% |
| Earnings Yield | 6.95% |
| FCF Yield | 3.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:532531 is 1,338.67, which is 34.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,338.67 |
| Price Target Difference | 34.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |